Most cited papers from Concept Foundation

Concept Foundation

What are the most cited papers from Concept Foundation?

The most cited paper from Concept Foundation is "Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics" (Andrea Ries Thurman, Thomas Kimble, Peter Edward Hall et al., 2012), with 18 citations. Next come "Pharmacokinetics of 10 mg of mifepristone" (13) and "Late follicular phase administration of mifepristone suppresses circulating leptin and FSH – mechanism(s) of action in emergency contraception?" (8).

Published TypeFieldAccess

Showing 12 of 12 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics Andrea Ries Thurman, Thomas Kimble, Peter Edward Hall et al. · Contraception	22 Dec 2012	18
2	Pharmacokinetics of 10 mg of mifepristone Riikka Leminen, Sirpa Ranta, Helena von Hertzen et al. · Contraception	Dec 2003	13
3	Late follicular phase administration of mifepristone suppresses circulating leptin and FSH – mechanism(s) of action in emergency contraception? Riikka Leminen, Taneli Raivio, Sirpa Ranta et al. · European Journal of Endocrinology	Mar 2005	8
4	A study of the capability of manufacturers of generic hormonal contraceptives in lower- and middle-income countries P.E. Hall, Joachim Oehler, Phillip Woo et al. · Contraception	17 Jan 2007	6
5	Regulatory standards and processes for over-the-counter availability of hormonal contraception and drugs for medical abortion in five countries in the Eastern Mediterranean Region Anne Ammerdorffer, Mark Laws, Arinze Awiligwe et al. · Health Research Policy and Systems Open access	Apr 2021	5
6	Protocol for a prospective cohort study on pre-eclampsia risk prediction in Ghana, Kenya and South Africa PEARLS study collaborators et al. · Reproductive Health Open access	27 Oct 2025	4
7	Is there evidence for tripling the dose of 200 mg mifepristone for medical abortion? Gilda GP Piaggio, Paul Van Look, Helena von Hertzen et al. · Contraception	16 Nov 2009	3
8	The compatibility of oxytocin and tranexamic acid injection products when mixed for co‐administration by infusion for the treatment of postpartum haemorrhage: An in vitro investigation Pete Lambert, Alessandra Tomazzini, Philip H. Wright et al. · BJOG An International Journal of Obstetrics & Gynaecology Open access	20 Jan 2023	1
9	Development of a novel method of misoprostol detection on filter paper: Proof-of-concept Grace Wu, Hatice Imran Gungordu, Navaporn Tagontong et al. · Biomedical Engineering Letters	May 2016	1
10	Expert consensus on pre-eclampsia risk screening tools for low- and middle-income countries: Development of a new Target Product Profile Annie R. A. McDougall, Tahlia Guneratne, Kate Mills et al. · PLOS Global Public Health Open access	2 Mar 2026	0
11	Protocol for a prospective accuracy study on an artificial intelligence-based ultrasound system for gestational age estimation among pregnant women in Ghana, Kenya and South Africa Alim Swarray-Deen, Annie R. A. McDougall, Rosa N. Chemway et al. · medRxiv PreprintOpen access	15 Feb 2026	0
12	Contraceptive-induced menstrual changes in low- and middle-income countries: a systematic scoping review Maureen Makama, Annie R. A. McDougall, Jenny Jung et al. · Communications Medicine Open access	17 Dec 2025	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.